Adapsyn Bioscience Inc., a Hamilton, On., Canada-based biotechnology company focused on the discovery and development of novel medicines derived from evolved small molecule natural products, completed a round of financing of undisclosed amount. Backers included Pfizer R&D Innovate and Genesys Capital. The company intends to use the funds for its internal drug development programs. Founded [...]
Adapsyn is a Canada-based chemical bioinformatics platform that develops novel small molecule therapies for the treatment of patients with tuberculosis.